Statin Drugs Gain Traction as Potential Treatment for Alzheimer's Disease
statins are gaining attention as a potential new way of treating Alzheimer's disease (AD) according to recent reports. The Wall Street Journal noted the promise of statins for Alzheimer's disease and highlighted the pressing need for new and effective treatments for this major disease (October 17, 2006 Several Drugs Show Promise For Alzheimer's). A series of recent scientific studies have explored the link between Alzheimer's disease, cognitive function and high cholesterol levels and other cardiovascular risk factors, and the possible role that statins may have in treating or preventing Alzheimer's disease.
Nymox Pharmaceutical Corporation holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of AD, including for patients at risk for AD because of vascular-related risk factors or disease.
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.